ENTITY

Immunovant Inc (IMVT US)

Analysis

Health Care • United States

Immunovant Inc operates as a biopharmaceutical company. The Company offers discovers and manufactures drugs for patients with autoimmune diseases. Immunovant serves customers worldwide.

Refresh

Focused

No publications yet

Add Immunovant Inc to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00